What is dyshidrosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dyshidrosis: Clinical Features and Management

Dyshidrosis is a recurrent vesicular skin condition characterized by pruritic, non-inflammatory vesicles primarily affecting the palms, soles, and lateral aspects of fingers, which may significantly impact quality of life and requires appropriate management strategies. 1

Clinical Features

Characteristic Presentation

  • Small, clear, deeply embedded vesicles beneath thick stratum corneum on palms, soles, and sides of fingers
  • Intense pruritus often preceding vesicle formation
  • Painful distension as vesicles enlarge
  • Vesicles typically resolve within 3 weeks but frequently recur 2
  • May present with various clinical forms:
    • Standard vesicular form
    • Bullous dyshidrosis (larger blisters)
    • Superinfected form
    • Psoriasiform keratoderma (chronic cases) 2

Differential Diagnosis

Dyshidrosis must be distinguished from other vesicular conditions affecting palms and soles:

  • Contact dermatitis (allergic or irritant)
  • Tinea manuum/pedis
  • Bullous pemphigoid (dyshidrosiform variant)
  • Pompholyx
  • Palmoplantar pustulosis 3

The dyshidrosiform variant of bullous pemphigoid is particularly important to recognize, as it typically presents in elderly patients with hemorrhagic or purpuric blisters on palms/soles before progressing to other body sites 3.

Etiology and Pathophysiology

Despite its name suggesting sweat gland dysfunction, dyshidrosis is not primarily related to hyperhidrosis or sweat gland abnormalities 4. It is considered a form of eczema with several potential triggers:

  • Atopic predisposition
  • Contact allergens
  • Fungal infections
  • Neurovegetative disturbances
  • Stress factors
  • Idiopathic causes 2, 4

Management Approach

First-Line Treatment

  1. Topical Corticosteroids

    • Medium potency corticosteroids for maintenance therapy
    • High/very high potency corticosteroids for severe flares 1
    • Apply twice daily during acute flares
  2. Skin Care and Prevention

    • Regular emollient application (at least once daily)
    • Avoid hot water, excessive soap use, and alcohol-containing products
    • Continue maintenance therapy even after resolution 1
    • Identify and eliminate triggering substances

Management of Fissures

  • Apply propylene glycol 50% in water for 30 minutes under plastic occlusion nightly
  • Follow with hydrocolloid dressing 1

Secondary Infection Management

  • Monitor for signs of secondary infection (usually Staphylococcus aureus)
  • Obtain bacterial cultures when suspected
  • Consider antiseptic baths with potassium permanganate (1:10,000) 1

Second-Line Treatment Options

Phototherapy

  • Oral PUVA therapy has shown superior efficacy compared to UVB for hand eczema
  • Significant improvement or clearance in 81-86% of patients with hand and foot eczema 5
  • Consider for cases not responding to topical treatments

Systemic Treatments

For severe, recalcitrant cases:

  • Immunomodulators (cyclosporine, methotrexate, azathioprine)
  • Biologics like dupilumab for severe cases 1

Special Considerations

Chronic Disease Management

  • Maintenance therapy with medium potency topical corticosteroids twice weekly to prevent relapses
  • Regular use of emollients is crucial for preventing recurrence 1

Occupational Impact

Dyshidrosis can cause significant occupational impairment, particularly in manual workers or those exposed to irritants 6. Consider:

  • Protective measures (cotton gloves under vinyl gloves)
  • Occupational modification if possible
  • Addressing psychological distress that may accompany chronic skin disease

Pitfalls and Caveats

  1. Misdiagnosis: Always rule out tinea infection with KOH preparation or fungal culture before initiating corticosteroid treatment
  2. Overtreatment: Prolonged use of high-potency topical corticosteroids can lead to skin atrophy
  3. Undertreatment: Inadequate treatment of acute flares may lead to chronicity
  4. Missing underlying causes: Failure to identify and address triggers will result in continued recurrences

When dyshidrosis is refractory to standard treatments, consider patch testing to identify potential contact allergens and evaluate for underlying systemic conditions that may be contributing to recurrent episodes.

References

Guideline

Eczema Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Dyshidrosis].

La Revue du praticien, 1998

Research

[How do I treat dyshidrosiform eruptions?].

Zeitschrift fur Hautkrankheiten, 1986

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Dyshidrosis: epidemiology, clinical characteristics, and therapy.

Dermatitis : contact, atopic, occupational, drug, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.